Closed-loop insulin delivery: We're "virtually" there

Diabetes Technology and Therapeutics

Volumn 14, Issue 3, 2012, Pages 203-204

  Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ALGORITHM; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; COMPUTER MODEL; DRUG DELIVERY SYSTEM; EDITORIAL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; METABOLIC REGULATION; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RISK REDUCTION; SENSOR;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE;

EID: 84857823308     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0261     Document Type: Editorial

References (8)

1. Panteleon AE, Loutseiko M, Steil GM, Rebrin K: Evaluation of the effect of gain on the meal response of an automated closedloop insulin delivery system. Diabetes 2006;55:1995-2000. (Pubitemid 44509972)
2. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery vs. semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
3. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350. (Pubitemid 44923591)
4. Kovatchev BP, Breton M, Man CD, Cobelli C: In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol 2009;3:44-55.
5. Schmidt S, Finan DA, Dunn-Henriksen AK, Jørgensen JB, Madsen H, Bengtsson H, Holst JJ, Madsbad S, Nørgaard K: Effects of everyday life events on glucose, insulin, and glucagon dynamics in continuous subcutaneous insulin infusion-treated type 1 diabetes: collection of clinical data for glucose modeling. Diabetes Technol Ther 2012;14:210-217.
6. Attia N, Jones TW, Holcombe J, Tamborlane WV: Comparison of human regular insulin and lispro insulin after interruption of CSII and in the treatment of acutely decompensated IDDM. Diabetes Care 1998;21:817-821. (Pubitemid 28487078)
7. Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F: Duration of nocturnal hypoglycemia before seizures. Diabetes Care 2008;31:2110-2112.
8. Cengiz E, Swan KL, Steil GM, Tamborlane WV, Steffen AT, Weinzimer SA: Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system. Diabetes Technol Ther 2009;11:207-210.